| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
4E1RCat
|
328998-25-0 |
4E1RCAT
|
4-[2,3-二氢-3-[[5-(4-硝基苯基)-2-呋喃基]亚甲基]-2-氧代-5-苯基-1H-吡咯-1-基]苯甲酸;CS-1228
|
C28H18N2O6 |
478.45232 | |
|
Mofegiline Hydrochloride
|
120635-25-8 |
莫非吉兰
|
CS-1216
|
C11H13F2N.ClH |
233.688 | |
|
DMH-1
|
1206711-16-1 |
DMH1
|
DMH1;DMH 1;DMH-1;4-[6-[4-异丙氧基苯基]吡唑并[1,5-A]嘧啶-3-基]喹啉;DMH 1;DMH-1
|
C24H20N4O |
380 | |
|
LDN-212854
|
1432597-26-6 |
(LDN212854)
|
5-[6-[4-(1-哌嗪基)苯基]吡唑并[1,5-A]嘧啶-3-基]喹啉;BMP INHIBITOR III;LDN212854;LDN 212854;CS-1202
|
C25H22N6 |
406.48238 | 808-898-3 |
|
VidofludiMus
|
717824-30-1 |
VIDOFLUDIMUS(4SC-11; SC12267)
|
|
C20H18FNO4 |
355.359623 | 615-418-4 |
|
BAMB-4
|
891025-25-5 |
CS-1193
|
ITPKA-IN-C14;BAMB-4
(ITPKA-IN-C14);BAMB-4
|
|||
|
Losmapimod
|
585543-15-3 |
Losmapimod (GW856553X)
|
CS-1186;6-[5-(环丙基氨基甲酰基(-3-氟-2-甲基苯基]-N-(2,2-二甲基丙基(吡啶-3-甲酰胺;洛批莫德
|
C22H26FN3O2 |
383.46 | |
|
Saxagliptin hydrate
|
945667-22-1 |
沙格列汀单水化合物
|
BMS-477118 HYDRATE;BMS 477118 HYDRATE;BMS477118 HYDRATE;CS-1180;沙格列汀单水化合物;沙格列汀水合物;沙格列汀一水合物(沙克列汀);萨格列汀;沙格列汀一水物;沙格列汀单水合物
|
C18H25N3O2.H2O |
333.42528 | 641-082-3 |
|
Apatinib (YN968D1)
|
811803-05-1 |
阿帕替尼
|
N-(4-(1-cyanocyclopentyl)phenyl)-2-(pyridin-4-ylMethylaMino)nicotinaMide;Mesylate APA;Apatinib Mesylate;N-[4-(1-Cyanocyclopentyl)phenyl]-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide Apatinib;3-Pyridinecarboxamide, N-[4-(1-cyanocyclopentyl)phenyl]-2-[(4-pyridinylmethyl)amino]-;Apatinib;Apatinib (YN968D1);Aptinib
|
C24H23N5O |
397.47232 | |
|
Tenovin-3
|
1011301-27-1 |
TENOVIN-3
|
N-[[(4-氨基苯基)氨基]硫代甲酰基]-4-(叔丁基)苯甲酰胺;N-((4-氨基苯基)硫代氨基甲酰基)-4-(叔丁基)苯甲酰胺;TENOVIN 3;TENOVIN3;CS-1154;1-(4-氨基-苯基)-3-(4-叔-丁基-苯甲酰基)-硫脲>98%
|
C18H21N3OS |
327.44384 | 200-256-5 |
|
TCS 359
|
301305-73-7 |
TCS 359
|
TCS359;T2-[(3,4-二甲氧基苯甲酰基)氨基]-4,5,6,7-四氢-苯并[B]噻吩-3-甲酰胺;2-(3,4-二甲氧基苯甲酰胺基)-4,7-四氢苯并[B]噻吩-3-甲酰胺
|
C18H20N2O4S |
360.432 | |
|
CC-930
|
899805-25-5 |
TANZISERTIB
|
CS-1152;TANZISERTIB;CC930;CC 930;TANZISERTIB (CC-930(
|
C21H23F3N6O2 |
448.44153 | |
|
Tamibarotene
|
94497-51-5 |
他米巴罗汀
|
CS-1151;AM80;AM 80;AM-80;他米巴罗汀;4-[(5,5,8,8-四甲基-6,7-二氢萘-2-基)氨基甲酰]苯甲酸;TAMIBAROTENE,AM 80,AM-80,AM80;他米巴罗丁
|
C22H25NO3 |
351.44 | 1806241-263-5 |
|
TAK-242
|
243984-11-4 |
瑞沙托维
|
CS-1150;RESATORVID;TAK242;TAK 242;瑞沙托维
|
C15H17ClFNO4S |
361.819 | |
|
SU14813
|
627908-92-3 |
SU-14813
|
CS-1149;SU-14813游离态;SU-14813;SU 14813;5-[(5-氟-1,2-二氢-2-氧代-3H-吲哚-3-亚基)甲基]-N-[(2S)-2-羟基-3-(4-吗啉基)丙基]-2,4-二甲基-1H-吡咯-3-甲酰胺
|
C23H27FN4O4 |
442.4832832 | |
|
FGFR inhibitor
|
848318-25-2 |
SSR128129E
|
2-氨基-5-[(1-甲氧基-2-甲基吲哚嗪-3-基)羰基]苯甲酸钠;CS-1148;SSR128129E;SSR 128129E;SSR-128129E.;SSR;SSR-128129E
|
C18H15N2NaO4 |
346.31247 | |
|
SKI II-SKI 2
|
312636-16-1 |
鞘氨醇激酶抑制剂
|
鞘氨醇激酶抑制剂;SPHINGOSINE KINASE INHIBITOR;SPHINGOSINE KINASE INHIBITOR 2;SKI II (SPHK-I2);SPHK-I2;SKI II (SPHINGOSINE KINASE INHIBITOR);鞘氨醇激酶抑制剂>98%;4-[[4-(4-氯苯基)-2-噻唑基]氨基]苯酚;
|
C15H11ClN2OS |
302.784 | |
|
SGI-1027
|
1020149-73-8 |
SGI-127
|
|
C27H23N7O |
461.51782 | |
|
SF1670(PTENinhibitor)
|
345630-40-2 |
SF167(PTENINHIBITOR)
|
PTEN抑制剂;N-(9,10-二氧代-9,10-二氢-菲-2-基)-2,2-二甲基丙酰胺;SF 1670;SF-1670
|
C19H17NO3 |
307.34318 | |
|
Semaxanib
|
194413-58-6 |
Semaxanib
|
3-[(3,5-二甲基-1H-吡咯-2-基)亚甲基]-1,3-二氢-2H-吲哚-3-酮
|
C15H14N2O |
238.289 |
药智官方微信
药智官方微博
